SYSTEMATIC AND SAMPLING MEDIASTINAL LYMPH NODE DISSECTION OF COMBINED TREATMENT OF NON-SMALL CELLS LUNG CANCER IIIA(N2) STAGE
https://doi.org/10.24060/2076-3093-2013-0-3-49-52
Abstract
This article provides results of combined modality treatment of patients with stage IIIA(N2) non-small cells lung cancer with systematic and selective lymph node dissection. Elicit that the selective lymph node dissection is valid for patients with stage IIIA(N2) squamous cell carcinoma and right-sided lung cancer when we provide combined modality treatment using adjuvant radiation therapy. Carrying out that the systematic lymph node dissection is extend disease-free survival and five-year survival rate when we provide combined modality treatment for patients with stage IIIA(N2) squamous cell carcinoma and left-sided lung cancer.
About the Authors
E. O. Mantsyrev
Chelyabinsk Regional Clinical Oncology Dispensary
Russian Federation
Russian Federation
A. V. Vazhenin
Chelyabinsk Regional Clinical Oncology Dispensary
Russian Federation
Russian Federation
O. A. Gladkov
Chelyabinsk Regional Clinical Oncology Dispensary
Russian Federation
Russian Federation
A. A. Lukin
Chelyabinsk Regional Clinical Oncology Dispensary
Russian Federation
Russian Federation
M. N. Mironchenko
Chelyabinsk Regional Clinical Oncology Dispensary
Russian Federation
Russian Federation
Ya. A. Gnatiuk
Chelyabinsk Regional Clinical Oncology Dispensary
Russian Federation
Russian Federation
S. N. Timofeev
Chelyabinsk Regional Clinical Oncology Dispensary
Russian Federation
Russian Federation
References
1. Онкология: национальное руководство / под ред. В.И. Чиссова, М.И Давыдова. – М.: ГЭОТАР-Медиа, 2008. – 1072 с.
2. Рак легкого / Под ред. В.И. Чиcсова. – М.: ГЕОТАР-Медиа, 2012. – 160 с.
3. Трахтенберг А.Х. Особенности диагностики и лечения рака легкого / А.Х. Трахтенберг, К.И. Колбанов, С.А. Седых // Пульмонология. – 2008. – №4. – С. 5-7.
4. Цыб А.Ф. Терапевтическая радиология: руководство для врачей / А.Ф. Цыб, Ю.С. Мардынский. – М.: ООО «МК», 2010. – 252 с.
5. Darling G.E. Randomized trial of mediastinal lymph node sampling versus complete lymphadenectomy during pulmonary resection in the patient with N0 or N1 (less than hilar) non-small cell carcinoma: results of the American College of Surgery Oncology Group Z0030 Trial / G.E. Darling, M.S. Allen // J. Thorac. Cardiovasc. Surg. – 2011. – Vol. 141. – P. 662-668.
6. Harvey I. P. Principles and Practice of Lung Cancer: The Official Reference Text of the International Association for the Study of Lung Cancer / I.P. Harvey. – 2010. – P. 1040.
7. Lardinois D. ESTS guidelines for intraoperative lymph node staging in non-small cell lung cancer / D. Lardinois, P. Leyn // Eur. J. Cardiothorac. Surg. – 2006. – Vol.30. – P. 787-792.
Review
For citations:
Mantsyrev E.O., Vazhenin A.V., Gladkov O.A., Lukin A.A., Mironchenko M.N., Gnatiuk Ya.A., Timofeev S.N. SYSTEMATIC AND SAMPLING MEDIASTINAL LYMPH NODE DISSECTION OF COMBINED TREATMENT OF NON-SMALL CELLS LUNG CANCER IIIA(N2) STAGE. Creative surgery and oncology. 2013;(3):49-52. (In Russ.) https://doi.org/10.24060/2076-3093-2013-0-3-49-52
Views:
835
Email this article 